Product Information
BCG (TICE STRAIN) VIAL is a brand product labeled by Merck Sharp & Dohme LLC, priced at $182.3029 per EA under NDC 00052060202. Its NADAC has been published 181 times since Feb 19, 2020.
Strength
50 mg/50mL
Manufacturer
Merck Sharp & Dohme LLCNDC
00052060202
Classification
Brand
Dosage Form
POWDER, FOR SUSPENSION
Route
INTRAVESICAL
Effective Date
3/28/2026
Active Ingredients
BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGENApproval Type
Biologic (BLA)
FDA Application
BLA102821On Market Since
8/24/1990
Pharmacological Classes
Price Statistics
The NADAC for BCG (TICE STRAIN) VIAL has been published 181 times since Feb 19, 2020, and over the history we have for it it has risen 19.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $182.3029 per EA |
|---|---|
| All-time high | $182.3029 (Sep 30, 2026) |
| All-time low | $152.8000 (Feb 19, 2020) |
| 52-week high | $182.3029 |
| 52-week low | $175.2895 |
| Median price | $163.3629 |
| Average price | $164.8722 |
| Largest weekly change | +4.0% (Apr 8, 2026) |
| Weeks tracked | 181 |
| Tracking since | Feb 19, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the BACILLUS CALMETTE-GUERIN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Merck Sharp & Dohme LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
BACILLUS CALMETTE-GUERIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BCG (TICE STRAIN) VIAL?
The current National Average Drug Acquisition Cost (NADAC) for BCG (TICE STRAIN) VIAL, manufactured by Merck Sharp & Dohme LLC, is $182.3029 per EA (NDC 00052060202), effective Sep 30, 2026.
How has the price of BCG (TICE STRAIN) VIAL changed over time?
Over the history we have for it, the NADAC for BCG (TICE STRAIN) VIAL has risen 19.3%. It has been tracked across 181 weekly CMS publications since Feb 19, 2020.
What are the highest and lowest recorded NADAC prices for BCG (TICE STRAIN) VIAL?
Since Feb 19, 2020, the NADAC for BCG (TICE STRAIN) VIAL has ranged from a low of $152.8000 (Feb 19, 2020) to a high of $182.3029 (Sep 30, 2026), with a median of $163.3629 per EA.
Are there cheaper alternatives to BCG (TICE STRAIN) VIAL?
No other NADAC-published product currently shares the active ingredient and strength of BCG (TICE STRAIN) VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BCG (TICE STRAIN) VIAL?
BCG (TICE STRAIN) VIAL (NDC 00052060202) is labeled by Merck Sharp & Dohme LLC, and CMS classifies it as a brand product.